Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

46.01
Delayed Data
As of Sep 30
 -0.28 / -0.60%
Today’s Change
45.76
Today|||52-Week Range
66.55
-29.91%
Year-to-Date
Amgen (AMGN) Migraine Drug Hits Phase III Primary Endpoint
Sep 30 / Zacks.com - Paid Partner Content
The Internet of Medical Things: 6 Stocks in Focus
Sep 26 / Zacks.com - Paid Partner Content
These Dogs May Soon Have Their Day
Sep 30 / TheStreet.com - Paid Partner Content
3 Dirt-Cheap Dividend Stocks You Can Buy Right Now
Sep 24 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Teva Pharmaceutical Industries, Intel, Sanofi, Alp...
Sep 27 / Zacks.com - Paid Partner Content
Teva Reports Positive Phase III Tardive Dyskinesia Data
Sep 23 / Zacks.com - Paid Partner Content
Clinton, Trump Share Big-Pharma Attack Goals, Andrew Left Says
Sep 26 / TheStreet.com - Paid Partner Content
Regeneron, Teva Collaborate to Develop Chronic Pain Drug
Sep 21 / Zacks.com - Paid Partner Content
Andrew Left Says Trump and Clinton Agree on Just One Thing
Sep 26 / TheStreet.com - Paid Partner Content
Teva Presents Top-Line Data from Huntington Disease Study
Sep 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close46.29
Today’s open46.36
Day’s range45.76 - 46.76
Volume13,279,547
Average volume (3 months)5,818,036
Market cap$47.0B
Dividend yield2.96%
Data as of 4:05pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-48.62%
Earnings growth (this year)-2.72%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-3.22%
P/E ratio30.9
Price/Sales2.89
Price/Book1.59

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+1.09+3.67%
OASMOasmia Pharmaceutica...-0.21-6.56%
Data as of 3:59pm ET, 09/30/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)$1.36
Annual revenue (last year)$19.6B
Annual profit (last year)$1.6B
Net profit margin8.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts

Search for Jobs